Saturday - June 22, 2024

Blissful Body Aesthetics Honored with Startup Achievement of the Year at the 9th Annual 2024 Globee® Awards for American Business

Blissful Body Aesthetics Named Winner at the 4th Annual 2024 Globee® Awards for Disruptors. Rahway, NJ – June 21, 2024 – Blissful Body Aesthetics is thrilled to announce that we have been honored with a Bronze award in the Startup Achievement of the Year at … Continue reading

New Book by Robert Siblerud Reveals Compelling Evidence Linking Mercury to Alzheimer’s Disease

Evidence Mercury Causes Alzheimer’s Disease” Explores the Impact of Dental Amalgam and Mercury Vapor on Neurodegenerative Health. Denver, CO – June 21, 2024 – Renowned author and researcher, Dr. Robert Siblerud, unveils groundbreaking scientific revelations in his latest book, “Evidence … Continue reading

Commercial & Industrial Energy Storage Systems: Cost Reduction & Efficiency

Introduction Commercial & Industrial Energy Storage Systems: Cost Reduction & Efficiency. As the economy changes, companies are increasingly focusing on energy cost management and operational efficiency optimization. Commercial energy storage systems have become a key solution, providing huge advantages in both areas. … Continue reading

Hunter Syndrome Pipeline 2024: Clinical Trials Assessment, FDA Approvals, Therapies, and Key Companies Involved by DelveInsight | REGENXBIO, Takeda, Triley Bidco, JCR Pharma, Sangamo Therapeutics

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Hunter Syndrome pipeline constitutes 10+ key companies continuously working towards developing 10+ Hunter Syndrome treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes … Continue reading

Polycythemia Vera Pipeline Insights 2024: Therapies, Clinical Trials, and Clinical Trials | F. Hoffmann-La Roche, Fujifilm Holdings Corp, Hangzhou Bensheng Pharma, Protagonist Therapeutics, Ascentage

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Polycythemia Vera pipeline constitutes 10+ key companies continuously working towards developing 10+ Polycythemia Vera treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes … Continue reading

Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insights | Alexza Pharma, Xenon Pharma, GW Pharma, Equilibre Biopharma, Takeda Pharma, Abide therapeutics, Otsuka pharma

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The … Continue reading

Osteosarcoma Pipeline Forecast 2024: FDA Approvals, Therapies, and Leading Companies | Pfizer Inc., Recordati Group, Takeda Pharma, Amgen, Baxter, Bayer AG, Hikma Pharma

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Osteosarcoma pipeline constitutes 25+ key companies continuously working towards developing 30+ Osteosarcoma treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The … Continue reading

Atrial Fibrillation Pipeline Report 2024: Drug Approvals and Clinical Trials Progress | Bayer, Johnson and Johnson, Bristol Myers-Squibb, Daiichi Sankyo, Pfizer, Anthos Therapeutics

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Atrial Fibrillation pipeline constitutes 15+ key companies continuously working towards developing 15+ Atrial Fibrillation treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes … Continue reading

Albert Jaskula’s Book, “The Fall,” Continues to Enjoy Widespread Acclaim for its Masterpiece Storytelling, Winning Awards Nonstop

At its release, the author might not have envisaged the book’s success but after many book tours and awards, Albert Jaskula can look back with a smile for producing an exceptional piece of art Albert Jaskula released “The Fall” last … Continue reading